David Christopher

发表

Evaluating Current Practices in Shelf Life Estimation

Robert Capen, David Christopher, Patrick Forenzo, 2017, AAPS PharmSciTech.

On the Shelf Life of Pharmaceutical Products

Svetlana Lyapustina, Terrence Tougas, Robert Capen, 2012, AAPS PharmSciTech.

Integrated genome sizing (IGS) approach for the parallelization of whole genome analysis

David Christopher, Jong Hui Hong, Hyung-Lae Kim, 2018, BMC Bioinformatics.

Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: Part 2—Evaluation of a method for determining equivalence

Svetlana Lyapustina, David Christopher, Yi Tsong, 2008, AAPS PharmSciTech.

Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 1: Background for a statistical method

Svetlana Lyapustina, David Christopher, Yi Tsong, 2007, AAPS PharmSciTech.

Product quality research institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 3: Final report on a statistical procedure for determining equivalence

Svetlana Lyapustina, Jolyon Mitchell, Steve Nichols, 2008, AAPS PharmSciTech.

Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)

Svetlana Lyapustina, Jolyon Mitchell, Terrence Tougas, 2012, AAPS PharmSciTech.

STANDARDS , REGULATIONS AND CURRENT PRACTICES FOR ORALLY INHALED AND NASAL DRUG PRODUCTS

Svetlana Lyapustina, David Christopher, Tim Chesworth, 2009 .

Evaluating the Performance of the ICH Guidelines for Shelf Life Estimation

David Christopher, Michelle Quinlan, James Schwenke, 2013, Journal of biopharmaceutical statistics.

Challenges and Opportunities in Implementing the FDA Default Parametric Tolerance Interval Two One-Sided Test for Delivered Dose Uniformity of Orally Inhaled Products

Svetlana Lyapustina, David Christopher, Helen Strickland, 2011, AAPS PharmSciTech.

Partitions with Fixed Number of Sizes

David Christopher, 2015, J. Integer Seq..

In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches

David Christopher, Beth Morgan, Ben Forbes, 2015, The AAPS Journal.

Comparison of two approaches for treating cascade impaction mass balance measurements.

Svetlana Lyapustina, Terrence Tougas, Bruce Wyka, 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Improved Quality Control Metrics for Cascade Impaction Measurements of Orally Inhaled Drug Products (OIPs)

Svetlana Lyapustina, Mike Van Oort, Bruce Wyka, 2009, AAPS PharmSciTech.

A Two One-Sided Parametric Tolerance Interval Test for Control of Delivered Dose Uniformity. Part 1—Characterization of FDA Proposed Test

Svetlana Lyapustina, Bruce Wyka, David Christopher, 2009, AAPS PharmSciTech.

Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.

Svetlana Lyapustina, Bing Li, Anthony J Hickey, 2010, Journal of aerosol medicine and pulmonary drug delivery.